search
Back to results

Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics (BR-102)

Primary Purpose

Aortic Stiffness, Hypertension

Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Pulse wave analysis measurement with Schiller BR-102 Plus PWA device
Sponsored by
University of Basel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Aortic Stiffness focused on measuring validation, pulse wave analysis, blood pressure monitoring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy individuals free of clinically relevant cardiovascular diseases or diabetes based on medical history and physical examination.
  • Heart rhythm: Sinus rhythm
  • Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high).

Exclusion Criteria:

  • Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles)
  • Pacemaker-dependent
  • Pregnancy after the 6th month of the pregnancy
  • Body mass index (BMI)>30 kg/m2
  • Known significant carotid or femoral artery stenosis
  • Impalpable arterial pulse at site of measurement
  • Age under 18 years.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Pulse wave analysis measurement

    Arm Description

    Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device

    Outcomes

    Primary Outcome Measures

    central blood pressure
    Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
    central arterial stiffness
    Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device

    Secondary Outcome Measures

    peripheral blood pressure
    Measurement peripheral blood pressure with the Schiller BR-102 Plus PWA device

    Full Information

    First Posted
    October 28, 2015
    Last Updated
    November 13, 2020
    Sponsor
    University of Basel
    Collaborators
    Kantonsspital Liestal
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02596165
    Brief Title
    Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics
    Acronym
    BR-102
    Official Title
    Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2020
    Overall Recruitment Status
    Terminated
    Why Stopped
    Stopp because of FDA concrns regarding recruitment.
    Study Start Date
    March 2016 (Actual)
    Primary Completion Date
    September 2016 (Actual)
    Study Completion Date
    October 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Basel
    Collaborators
    Kantonsspital Liestal

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The significance of parameters of the central hemodynamic is based upon their strong association with left ventricular hypertrophy and target organ damage at the heart. Noninvasive, auscultatory/ oscillometric and therefore easy applicable measurements of the central hemodynamic such as presented by the Schiller BR-102 plus PWA device implicate highly promising potential for research and daily clinical praxis for improved cardiovascular risk assessment on the population level. The purpose of this study is to evaluate the validity of the central and peripheral blood pressure and central arterial stiffness measured with the device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland).
    Detailed Description
    The proposed study is an open, monocentric cross-sectional research study for the evaluation of the validity of the central and peripheral blood pressure and central arterial stiffness measured with the device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland). For that purpose measurement of the respective parameters in cardiovascular disease free individuals will be compared with validated devices and the agreement between the devices will be statistically analyzed. Central blood pressure and central arterial stiffness are clinically increasingly meaningful parameters of the cardiovascular system that allow improved, early cardiovascular risk stratification. The significance of parameters of the central hemodynamic is based upon their strong association with left ventricular hypertrophy and target organ damage at the heart. Noninvasive, auscultatory/ oscillometric and therefore easy applicable measurements of the central hemodynamic such as presented by the Schiller BR-102 plus PWA device implicate highly promising potential for research and daily clinical praxis for improved cardiovascular risk assessment on the population level.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Aortic Stiffness, Hypertension
    Keywords
    validation, pulse wave analysis, blood pressure monitoring

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    45 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Pulse wave analysis measurement
    Arm Type
    Experimental
    Arm Description
    Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
    Intervention Type
    Device
    Intervention Name(s)
    Pulse wave analysis measurement with Schiller BR-102 Plus PWA device
    Intervention Description
    Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
    Primary Outcome Measure Information:
    Title
    central blood pressure
    Description
    Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
    Time Frame
    1 day
    Title
    central arterial stiffness
    Description
    Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
    Time Frame
    1 day
    Secondary Outcome Measure Information:
    Title
    peripheral blood pressure
    Description
    Measurement peripheral blood pressure with the Schiller BR-102 Plus PWA device
    Time Frame
    1 day

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Healthy individuals free of clinically relevant cardiovascular diseases or diabetes based on medical history and physical examination. Heart rhythm: Sinus rhythm Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high). Exclusion Criteria: Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles) Pacemaker-dependent Pregnancy after the 6th month of the pregnancy Body mass index (BMI)>30 kg/m2 Known significant carotid or femoral artery stenosis Impalpable arterial pulse at site of measurement Age under 18 years.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Arno Schmidt-Trucksäss, MD, MA
    Organizational Affiliation
    Department for Sport, Exercise and Health, Sports and Exercise Medicine, University of Basel, Basel, Switzerland, 4052
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics

    We'll reach out to this number within 24 hrs